These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 28692169)

  • 41. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
    Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
    Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy.
    Zanichelli A; Arcoleo F; Barca MP; Borrelli P; Bova M; Cancian M; Cicardi M; Cillari E; De Carolis C; De Pasquale T; Del Corso I; Di Rocco PC; Guarino MD; Massaro I; Minale P; Montinaro V; Neri S; Perricone R; Pucci S; Quattrocchi P; Rossi O; Triggiani M; Zanierato G; Zoli A
    Orphanet J Rare Dis; 2015 Feb; 10():11. PubMed ID: 25758562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting.
    Zanichelli A; Longhurst HJ; Maurer M; Bouillet L; Aberer W; Fabien V; Andresen I; Caballero T;
    Ann Allergy Asthma Immunol; 2016 Oct; 117(4):394-398. PubMed ID: 27742086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study.
    Martinez-Saguer I; Rusicke E; Aygören-Pürsün E; von Hentig N; Klingebiel T; Kreuz W
    Transfusion; 2010 Feb; 50(2):354-60. PubMed ID: 19788511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coagulation Factor XII Gene Mutation in Brazilian Families with Hereditary Angioedema with Normal C1 Inhibitor.
    Moreno AS; Valle SO; Levy S; França AT; Serpa FS; Arcuri HA; Palma MS; Campos WN; Dias MM; Ponard D; Monnier N; Lunardi J; Bork K; Silva WA; Arruda LK
    Int Arch Allergy Immunol; 2015; 166(2):114-20. PubMed ID: 25790805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High attack frequency in patients with angioedema due to C1-inhibitor deficiency is a major determinant in switching to home therapy: a real-life observational study.
    Squeglia V; Barbarino A; Bova M; Gravante C; Petraroli A; Spadaro G; Triggiani M; Genovese A; Marone G
    Orphanet J Rare Dis; 2016 Sep; 11(1):133. PubMed ID: 27686124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hereditary angioedema education in otolaryngology residencies: survey of program directors.
    Patel VA; Siddique L; Stahl L; Carr MM
    Int Forum Allergy Rhinol; 2018 Jul; 8(7):850-856. PubMed ID: 29543388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
    Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
    Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks.
    Grant JA; White MV; Li HH; Fitts D; Kalfus IN; Uknis ME; Lumry WR
    Allergy Asthma Proc; 2012; 33(4):348-53. PubMed ID: 22856635
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frequent life-threatening laryngeal attacks in two Croatian families with hereditary angioedema due to C1 inhibitor deficiency harbouring a novel frameshift mutation in SERPING1.
    Karadža-Lapić L; Korošec P; Šilar M; Košnik M; Cikojević D; Lozić B; Rijavec M
    Ann Med; 2016 Nov; 48(7):485-491. PubMed ID: 27187751
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema.
    Aygören-Pürsün E; Soteres DF; Nieto-Martinez SA; Christensen J; Jacobson KW; Moldovan D; Van Leerberghe A; Tang Y; Lu P; Vardi M; Schranz J; Martinez-Saguer I
    Pediatr Allergy Immunol; 2019 Aug; 30(5):553-561. PubMed ID: 30968444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Levels of the Lectin Pathway Serine Protease MASP-1 and Its Complex Formation with C1 Inhibitor Are Linked to the Severity of Hereditary Angioedema.
    Hansen CB; Csuka D; Munthe-Fog L; Varga L; Farkas H; Hansen KM; Koch C; Skjødt K; Garred P; Skjoedt MO
    J Immunol; 2015 Oct; 195(8):3596-604. PubMed ID: 26371246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of chromogenic and ELISA functional C1 inhibitor tests in diagnosing hereditary angioedema.
    Li HH; Busse P; Lumry WR; Frazer-Abel A; Levy H; Steele T; Dayno J; Riedl M
    J Allergy Clin Immunol Pract; 2015; 3(2):200-5. PubMed ID: 25609336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Icatibant Outcome Survey in Patients with Hereditary Angioedema: Experience in Israel Compared with Other Countries.
    Toubi E; Kivity S; Graif Y; Reshef A; Botha J; Andresen I
    Isr Med Assoc J; 2018 Apr; 20(4):227-232. PubMed ID: 29629730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in Sweden.
    Nordenfelt P; Dawson S; Wahlgren CF; Lindfors A; Mallbris L; Björkander J
    Allergy Asthma Proc; 2014; 35(2):185-90. PubMed ID: 24411585
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preventing Hereditary Angioedema Attacks in Children Using Cinryze®: Interim Efficacy and Safety Phase 3 Findings.
    Aygören-Pürsün E; Soteres D; Moldovan D; Christensen J; Van Leerberghe A; Hao J; Schranz J; Jacobson KW; Martinez-Saguer I
    Int Arch Allergy Immunol; 2017; 173(2):114-119. PubMed ID: 28662509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decreasing Attacks and Improving Quality of Life through a Systematic Management Program for Patients with Hereditary Angioedema.
    Nunes FL; Ferriani MPL; Moreno AS; Langer SS; Maia LSM; Ferraro MF; Sarti W; Bessa Junior J; Cunha D; Suffritti C; Dias MM; Januário YC; daSilva LLP; Aragon DC; Caballero T; Arruda LK
    Int Arch Allergy Immunol; 2021; 182(8):697-708. PubMed ID: 33657571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of ficolins and MASPs in hereditary angioedema due to C1-inhibitor deficiency.
    Csuka D; Munthe-Fog L; Skjoedt MO; Kocsis A; Zotter Z; Gál P; Varga L; Farkas H; Füst G; Garred P
    Mol Immunol; 2013 Jul; 54(3-4):271-7. PubMed ID: 23318225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency.
    Bork K; Bernstein JA; Machnig T; Craig TJ
    J Emerg Med; 2016 Apr; 50(4):567-80.e1. PubMed ID: 26826769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hereditary Angioedema with Normal C1 Inhibitor and F12 Mutations in 42 Brazilian Families.
    Veronez CL; Moreno AS; Constantino-Silva RN; Maia LSM; Ferriani MPL; Castro FFM; Valle SR; Nakamura VK; Cagini N; Gonçalves RF; Mansour E; Serpa FS; Coelho Dias GA; Piccirillo MA; Toledo E; de Souza Bernardes M; Cichon S; Stieber C; Arruda LK; Pesquero JB; Grumach AS
    J Allergy Clin Immunol Pract; 2018; 6(4):1209-1216.e8. PubMed ID: 29128335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.